0000950170-23-043479.txt : 20230818
0000950170-23-043479.hdr.sgml : 20230818
20230818163021
ACCESSION NUMBER: 0000950170-23-043479
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230801
FILED AS OF DATE: 20230818
DATE AS OF CHANGE: 20230818
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cullen Kevin Joseph
CENTRAL INDEX KEY: 0001858836
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39242
FILM NUMBER: 231186215
MAIL ADDRESS:
STREET 1: AVEO PHARMACEUTICALS, INC.
STREET 2: 30 WINTER STREET
CITY: BOSTON
STATE: MA
ZIP: 02108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: California BanCorp
CENTRAL INDEX KEY: 0001752036
STANDARD INDUSTRIAL CLASSIFICATION: STATE COMMERCIAL BANKS [6022]
IRS NUMBER: 821751097
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1300 CLAY STREET
STREET 2: SUITE 500
CITY: OAKLAND
STATE: CA
ZIP: 94612
BUSINESS PHONE: 510-457-3769
MAIL ADDRESS:
STREET 1: 1300 CLAY STREET
STREET 2: SUITE 500
CITY: OAKLAND
STATE: CA
ZIP: 94612
4
1
ownership.xml
4
X0508
4
2023-08-01
0001752036
California BanCorp
CALB
0001858836
Cullen Kevin Joseph
1300 CLAY STREET, SUITE 500
OAKLAND
CA
94612
true
false
false
false
false
Common Stock
2023-08-01
4
A
false
645
18.60
A
45894
D
These shares were issued to the reporting person under the issuer's Amended and Restated 2017 Equty Incentive Plan in lieu of director retainer and meeting fees of $12,000.
/s/ Kevin J. Cullen, by Debra Bradford, attorney-in-fact
2023-08-18